180 related articles for article (PubMed ID: 7680089)
1. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.
Bujía J; Kim C; Holly A; Sudhoff H; Ostos P; Kastenbauer E
Am J Otol; 1996 Mar; 17(2):203-6. PubMed ID: 8723947
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
Ergün S; Zheng X; Carlsöö B
Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
[TBL] [Abstract][Full Text] [Related]
5. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
[TBL] [Abstract][Full Text] [Related]
6. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
[TBL] [Abstract][Full Text] [Related]
7. [Autocrine growth mechanisms of cholesteatoma epithelium].
Schilling V; Holly A; Bujía J; Schulz P
Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
[TBL] [Abstract][Full Text] [Related]
8. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
[TBL] [Abstract][Full Text] [Related]
9. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
Holly A; Bujía J; Sanchez-Madrid F
Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
[TBL] [Abstract][Full Text] [Related]
10. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
[TBL] [Abstract][Full Text] [Related]
11. [Hyperproliferation-associated keratin 16 expression in cholesteatoma].
Schilling V; Bujía J; Holly A; Schulz P
Laryngorhinootologie; 1992 Nov; 71(11):584-7. PubMed ID: 1281411
[TBL] [Abstract][Full Text] [Related]
12. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
Piepkorn M; Predd H; Underwood R; Cook P
Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
Holly A; Sittinger M; Bujía J
Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
[TBL] [Abstract][Full Text] [Related]
14. Expression of involucrin in human middle ear cholesteatoma.
Chao WY; Huang CC
Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
[TBL] [Abstract][Full Text] [Related]
16. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
[TBL] [Abstract][Full Text] [Related]
17. Cholesteatoma: a molecular and cellular puzzle.
Albino AP; Kimmelman CP; Parisier SC
Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
[TBL] [Abstract][Full Text] [Related]
18. [Epidermal Langerhans cells in cholesteatoma].
Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(3):150-1, 189. PubMed ID: 2702007
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
Holly A; Sittinger M; Bujia J
Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
[TBL] [Abstract][Full Text] [Related]
20. The role of S100A1 in external auditory canal cholesteatoma.
Naim R; Hormann K
Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
